Literature DB >> 3763539

Fifteen year survival of patients presenting with hypertension to a hospital clinic.

C J Bulpitt, P F Bulpitt, M Daymond, K Hartley, C T Dollery.   

Abstract

The survival has been determined for the 404 patients who presented to the Hammersmith Hospital Hypertension Clinic during the years 1962 to 1966 and in whom the untreated blood pressure was known. The fifteen year survival ranged from 72% for young men aged 30-49 at presentation to 27% for men aged 60-69. Sixty-eight percent of the deaths were cardiovascular or renal, 33% of all deaths were from ischaemic heart disease (IHD), 17% from stroke and 3% from renal causes. Death from any cause was predicted with statistical significance by age, the presence of accelerated or malignant hypertension, impaired renal function, smoking at presentation and systolic blood pressure. Death was not predicted by hypokalaemia, hyperuricaemia (after adjusting for renal function) and obesity.

Entities:  

Mesh:

Year:  1986        PMID: 3763539      PMCID: PMC2418698          DOI: 10.1136/pgmj.62.727.335

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

2.  A computer program for comparing K samples with right-censored data.

Authors:  E T Lee; M M Desu
Journal:  Comput Programs Biomed       Date:  1972-11

3.  Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967.

Authors:  A Breckenridge; C T Dollery; E H Parry
Journal:  Q J Med       Date:  1970-07

4.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

5.  Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.

Authors:  C J Bulpitt; L J Beilin; P Clifton; E C Coles; C T Dollery; J S Gear; G S Harper; B F Johnson; A D Munro-Faure
Journal:  Lancet       Date:  1979-07-21       Impact factor: 79.321

  5 in total
  1 in total

1.  Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study.

Authors:  P S Patki; J Singh; S V Gokhale; P M Bulakh; D S Shrotri; B Patwardhan
Journal:  BMJ       Date:  1990-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.